|
|
.
See Category: Diseases of the respiratory system
ICD-10 (CM) Code and Descriptor
|
J82.83 |
Eosinophilic asthma
|
J8283 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 33.68%
|
31.13%
|
9.76%
|
6.14%
|
4.34%
|
3.58%
|
2.64%
|
2.21%
|
1.56%
|
1.13%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for J82.83*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
3,889
|
4,053
|
|
J2182
|
INJECTION, MEPOLIZUMAB, 1MG |
2,750
|
280,156
|
|
J0517
|
INJ., BENRALIZUMAB, 1 MG |
1,127
|
33,665
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
969
|
970
|
|
96401
|
CHEMO ANTI-NEOPL SQ/IM |
374
|
428
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
361
|
364
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
331
|
332
|
|
J2357
|
OMALIZUMAB INJECTION |
269
|
10,110
|
|
J2786
|
INJECTION, RESLIZUMAB, 1MG |
156
|
39,950
|
|
80053
|
COMPREHEN METABOLIC PANEL |
140
|
140
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
110
|
110
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
105
|
105
|
|
82785
|
ASSAY OF IGE |
99
|
99
|
|
94729
|
CO/MEMBANE DIFFUSE CAPACITY |
97
|
97
|
|
94060
|
EVALUATION OF WHEEZING |
95
|
95
|
|
94010
|
BREATHING CAPACITY TEST |
92
|
92
|
|
86003
|
ALLG SPEC IGE CRUDE XTRC EA |
75
|
850
|
|
71046
|
X-RAY EXAM CHEST 2 VIEWS |
74
|
74
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
73
|
73
|
|
96413
|
CHEMO IV INFUSION 1 HR |
64
|
64
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
J82.83 related to the following DRG Codes:
196-198
|
